Selvita Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Boguslaw Sieczkowski
Chief executive officer
zł1.1m
Total compensation
CEO salary percentage | 59.8% |
CEO tenure | no data |
CEO ownership | 5.1% |
Management average tenure | 2.3yrs |
Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | zł65m |
Dec 31 2023 | zł1m | zł658k | zł70m |
Sep 30 2023 | n/a | n/a | zł20m |
Jun 30 2023 | n/a | n/a | zł31m |
Mar 31 2023 | n/a | n/a | zł24m |
Dec 31 2022 | zł1m | zł480k | zł26m |
Sep 30 2022 | n/a | n/a | zł20m |
Jun 30 2022 | n/a | n/a | zł11m |
Mar 31 2022 | n/a | n/a | zł12m |
Dec 31 2021 | zł1m | zł1m | zł15m |
Sep 30 2021 | n/a | n/a | zł12m |
Jun 30 2021 | n/a | n/a | zł18m |
Mar 31 2021 | n/a | n/a | zł22m |
Dec 31 2020 | zł697k | n/a | zł18m |
Sep 30 2020 | n/a | n/a | zł21m |
Jun 30 2020 | n/a | n/a | zł15m |
Mar 31 2020 | n/a | n/a | zł9m |
Dec 31 2019 | zł186k | zł113k | zł7m |
Compensation vs Market: Boguslaw's total compensation ($USD272.33K) is below average for companies of similar size in the German market ($USD760.26K).
Compensation vs Earnings: Boguslaw's compensation has been consistent with company performance over the past year.
CEO
Boguslaw Sieczkowski
no data
Tenure
zł1,100,903
Compensation
Mr. Boguslaw Stanislaw Sieczkowski, M.B.A, is Chief Executive Officer and Chairman of Management Board at SELVITA S.A. Mr. Sieczkowski served as Chief Operating Officer, Executive Vice President and Vice P...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of Management Board & CEO | no data | zł1.10m | 5.13% PLN 14.1m | |
Chief Commercial Officer | no data | zł1.09m | 0.33% PLN 906.9k | |
CFO & Member of the Management Board | 4.8yrs | zł590.72k | 0.023% PLN 64.0k | |
COO & Member of the Management Board | 2.3yrs | zł644.19k | 0.23% PLN 640.4k | |
General Counsel & Member of the Management Board | no data | zł672.21k | 0.024% PLN 66.7k | |
Global Head of Drug Discovery & Member of the Management Board | 2.3yrs | zł1.25m | 0.065% PLN 179.1k |
2.3yrs
Average Tenure
Experienced Management: 787's management team is considered experienced (2.3 years average tenure).